HIV-infected dendritic cells present endogenous MHC class II-restricted antigens to HIV-specific CD4+ T cells

Journal of Immunology

Volumn 197, Issue 2, 2016, Pages 517-532

  Coulon, Pierre Grégoire ^a   Richetta, Clémence ^a   Rouers, Angéline ^a   Blanchet, Fabien P ^b   Urrutia, Alejandra ^a   Guerbois, Mathilde ^c   Piguet, Vincent ^d   Theodorou, Ioannis ^a,e   Bet, Anne ^a   Schwartz, Olivier ^c   Tangy, Frédéric ^c   Graff Dubois, Stéphanie ^a   Cardinaud, Sylvain ^a   Moris, Arnaud ^a,e  

^a SORBONNE UNIVERSITÉ   (France)

^b University of Montpellier I and II   (France)

^c INSTITUT PASTEUR   (France)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN L CHAIN 3; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CD4+ T LYMPHOCYTE; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; THYMUS; CONFOCAL MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; VIROLOGY; WESTERN BLOTTING;

ANTIGEN PRESENTATION; AUTOPHAGY; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL;

EID: 84978091696     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600286     Document Type: Article

References (88)

1. Porichis, F., and D. E. Kaufmann. 2011. HIV-specific CD4 T cells and immune control of viral replication. Curr. Opin. HIV AIDS 6: 174-180.
2. Ranasinghe, S., M. Flanders, S. Cutler, D. Z. Soghoian, M. Ghebremichael, I. Davis, M. Lindqvist, F. Pereyra, B. D. Walker, D. Heckerman, and H. Streeck. 2012. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J. Virol. 86: 277-283.
3. Schieffer, M., H. K. Jessen, A. F. Oster, F. Pissani, D. Z. Soghoian, R. Lu, A. B. Jessen, C. Zedlack, B. T. Schultz, I. Davis, et al. 2014. Induction of Gagspecific CD4 T cell responses during acute HIV infection is associated with improved viral control. J. Virol. 88: 7357-7366.
4. + T cell responses with HIV immune control. Nat. Med. 19: 930-933.
5. + T cells and macrophages. J. Virol. 83: 7668-7677.
6. Mantegazza, A. R., J. G. Magalhaes, S. Amigorena, and M. S. Marks. 2013. Presentation of phagocytosed antigens by MHC class I and II. Traffic 14: 135-152.
7. Eisenlohr, L. C., N. Luckashenak, S. Apcher, M. A. Miller, and G. Sinnathamby. 2011. Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways. Immunol. Res. 51: 237-248.
8. Yuseff, M. I., A. Reversat, D. Lankar, J. Diaz, I. Fanget, P. Pierobon, V. Randrian, N. Larochette, F. Vascotto, C. Desdouets, et al. 2011. Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. Immunity 35: 361-374.
9. Moss, C. X., T. I. Tree, and C. Watts. 2007. Reconstruction of a pathway of antigen processing and class II MHC peptide capture. EMBO J. 26: 2137-2147.
10. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375: 603-606.
11. Sinnathamby, G., and L. C. Eisenlohr. 2003. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. J. Immunol. 170: 3504-3513.
12. Tewari, M. K., G. Sinnathamby, D. Rajagopal, and L. C. Eisenlohr. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6: 287-294.
13. Sekaly, R. P., S. Jacobson, J. R. Richert, C. Tonnelle, H. F. McFarland, and E. O. Long. 1988. Antigen presentation to HLA class II-restricted measles virusspecific T-cell clones can occur in the absence of the invariant chain. Proc. Natl. Acad. Sci. USA 85: 1209-1212.
14. Jacobson, S., R. P. Sekaly, W. J. Bellini, C. L. Johnson, H. F. McFarland, and E. O. Long. 1988. Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes. Ann. N. Y. Acad. Sci. 540: 352-353.
15. + T cell response to influenza. Nat. Med. 21: 1216-1222.
16. Nuchtern, J. G., W. E. Biddison, and R. D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343: 74-76.
17. Miller, M. A., A. P. Ganesan, and L. C. Eisenlohr. 2013. Toward a network model of MHC class II-restricted antigen processing. Front. Immunol. 4: 464.
18. Dengjel, J., O. Schoor, R. Fischer, M. Reich, M. Kraus, M. Muller, K. Kreymborg, F. Altenberend, J. Brandenburg, H. Kalbacher, et al. 2005. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. USA 102: 7922-7927.
19. Paludan, C., D. Schmid, M. Landthaler, M. Vockerodt, D. Kube, T. Tuschl, and C. Munz. 2005. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307: 593-596.
20. Mizushima, N. 2007. Autophagy: process and function. Genes Dev. 21: 2861-2873.
21. Esclatine, A., M. Chaumorcel, and P. Codogno. 2009. Macroautophagy signaling and regulation. Curr. Top. Microbiol. Immunol. 335: 33-70.
22. Wenger, T., S. Terawaki, V. Camosseto, R. Abdelrassoul, A. Mies, N. Catalan, N. Claudio, G. Clavarino, A. de Gassart, Fde. A. Rigotti, et al. 2012. Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation. Autophagy 8: 350-363.
23. English, L., M. Chemali, J. Duron, C. Rondeau, A. Laplante, D. Gingras, D. Alexander, D. Leib, C. Norbury, R. Lippé, and M. Desjardins. 2009. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat. Immunol. 10: 480-487.
24. Tey, S. K., and R. Khanna. 2012. Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway. Blood 120: 994-1004.
25. Dörfel, D., S. Appel, F. Grunebach, M. M. Weck, M. R. Muller, A. Heine, and P. Brossart. 2005. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA. Blood 105: 3199-3205.
26. Schmid, D., M. Pypaert, and C. Munz. 2007. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26: 79-92.
27. Ireland, J. M., and E. R. Unanue. 2011. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J. Exp. Med. 208: 2625-2632.
28. Jagannath, C., D. R. Lindsey, S. Dhandayuthapani, Y. Xu, R. L. Hunter, Jr., and N. T. Eissa. 2009. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med. 15: 267-276.
29. Leung, C. S., T. A. Haigh, L. K. Mackay, A. B. Rickinson, and G. S. Taylor. 2010. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc. Natl. Acad. Sci. USA 107: 2165-2170.
30. Lee, H. K., L. M. Mattei, B. E. Steinberg, P. Alberts, Y. H. Lee, A. Chervonsky, N. Mizushima, S. Grinstein, and A. Iwasaki. 2010. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32: 227-239.
31. Comber, J. D., T. M. Robinson, N. A. Siciliano, A. E. Snook, and L. C. Eisenlohr. 2011. Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class IIrestricted presentation. J. Virol. 85: 6453-6463.
32. Blanchet, F. P., A. Moris, D. S. Nikolic, M. Lehmann, S. Cardinaud, R. Stalder, E. Garcia, C. Dinkins, F. Leuba, L. Wu, et al. 2010. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32: 654-669.
33. Steinman, R. M. 2000. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100: 491-494.
34. Moris, A., C. Nobile, F. Buseyne, F. Porrot, J. P. Abastado, and O. Schwartz. 2004. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103: 2648-2654.
35. Turville, S. G., J. J. Santos, I. Frank, P. U. Cameron, J. Wilkinson, M. Miranda-Saksena, J. Dable, H. Stössel, N. Romani, M. Piatak, Jr., et al. 2004. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103: 2170-2179.
36. + T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108: 1643-1651.
37. Rodriguez-Plata, M. T., A. Urrutia, S. Cardinaud, M. J. Buzón, N. Izquierdo-Useros, J. G. Prado, M. C. Puertas, I. Erkizia, P. G. Coulon, S. Cedeño, et al. 2012. HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activation. J. Immunol. 188: 6036-6045.
38. Centlivre, M., N. Legrand, R. Steingrover, R. van der Sluis, M. L. Grijsen, M. Bakker, S. Jurriaans, B. Berkhout, W. A. Paxton, J. M. Prins, and G. Pollakis. 2011. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J. Leukoc. Biol. 89: 785-795.
39. Donaghy, H., A. Pozniak, B. Gazzard, N. Qazi, J. Gilmour, F. Gotch, and S. Patterson. 2001. Loss of blood CD11c+ myeloid and CD11c2 plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98: 2574-2576.
40. Patterson, S., M. S. Roberts, N. R. English, S. E. Macatonia, M. N. Gompels, A. J. Pinching, and S. C. Knight. 1994. Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals. Res. Virol. 145: 171-176.
41. Granelli-Piperno, A., I. Shimeliovich, M. Pack, C. Trumpfheller, and R. M. Steinman. 2006. HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J. Immunol. 176: 991-998.
42. Donaghy, H., B. Gazzard, F. Gotch, and S. Patterson. 2003. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101: 4505-4511.
43. Hertoghs, N., A. M. van der Aar, L. C. Setiawan, N. A. Kootstra, S. I. Gringhuis, and T. B. Geijtenbeek. 2015. SAMHD1 degradation enhances active suppression of dendritic cell maturation by HIV-1. J. Immunol. 194: 4431-4437.
44. Nobile, C., C. Petit, A. Moris, K. Skrabal, J. P. Abastado, F. Mammano, and O. Schwartz. 2005. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79: 5386-5399.
45. Su, B., M. E. Biedma, A. Lederle, M. Peressin, M. Lambotin, A. Proust, T. Decoville, S. Schmidt, G. Laumond, and C. Moog. 2014. Dendritic celllymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells. J. Virol. 88: 5109-5121.
46. Manel, N., B. Hogstad, Y. Wang, D. E. Levy, D. Unutmaz, and D. R. Littman. 2010. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467: 214-217.
47. Harman, A. N., N. Nasr, A. Feetham, A. Galoyan, A. A. Alshehri, D. Rambukwelle, R. A. Botting, B. M. Hiener, E. Diefenbach, R. J. Diefenbach, et al. 2015. HIV blocks interferon induction in human dendritic cells and macrophages by dysregulation of TBK1. J. Virol. 89: 6575-6584.
48. Simon, V., N. Bloch, and N. R. Landau. 2015. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat. Immunol. 16: 546-553.
49. Laguette, N., B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane. 2011. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
50. Lahouassa, H., W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue, L. Dragin, N. Bloch, C. Maudet, M. Bertrand, T. Gramberg, et al. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13: 223-228.
51. Schubert, U., L. C. Antón, J. Gibbs, C. C. Norbury, J. W. Yewdell, and J. R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770-774.
52. Nermut, M. V., W. H. Zhang, G. Francis, F. Ciampor, Y. Morikawa, and I. M. Jones. 2003. Time course of Gag protein assembly in HIV-1-infected cells: a study by immunoelectron microscopy. Virology 305: 219-227.
53. Dunbar, S. A. 2006. Applications of Luminex xMAP technology for rapid, highthroughput multiplexed nucleic acid detection. Clin. Chim. Acta 363: 71-82.
54. + cell depletion. Cell 54: 561-575.
55. Fujita, N., M. Hayashi-Nishino, H. Fukumoto, H. Omori, A. Yamamoto, T. Noda, and T. Yoshimori. 2008. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol. Biol. Cell 19: 4651-4659.
56. Kabeya, Y., N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y. Ohsumi, and T. Yoshimori. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19: 5720-5728.
57. Berger, G., S. Durand, C. Goujon, X. N. Nguyen, S. Cordeil, J. L. Darlix, and A. Cimarelli. 2011. A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors. Nat. Protoc. 6: 806-816.
58. Casartelli, N., F. Guivel-Benhassine, R. Bouziat, S. Brandler, O. Schwartz, and A. Moris. 2010. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J. Exp. Med. 207: 39-49.
59. Testa, J. S., G. S. Apcher, J. D. Comber, and L. C. Eisenlohr. 2010. Exosomedriven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin. J. Immunol. 185: 6608-6616.
60. Rowell, J. F., P. E. Stanhope, and R. F. Siliciano. 1995. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J. Immunol. 155: 473-488.
61. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo, O. Schwartz, and P. Benaroch. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98: 12144-12149.
62. Bania, J., E. Gatti, H. Lelouard, A. David, F. Cappello, E. Weber, V. Camosseto, and P. Pierre. 2003. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc. Natl. Acad. Sci. USA 100: 6664-6669.
63. Kyei, G. B., C. Dinkins, A. S. Davis, E. Roberts, S. B. Singh, C. Dong, L. Wu, E. Kominami, T. Ueno, A. Yamamoto, et al. 2009. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186: 255-268.
64. Espert, L., M. Varbanov, V. Robert-Hebmann, S. Sagnier, I. Robbins, F. Sanchez, V. Lafont, and M. Biard-Piechaczyk. 2009. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 4: e5787.
65. Heckmann, B. L., X. Yang, X. Zhang, and J. Liu. 2013. The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes. Br. J. Pharmacol. 168: 163-171.
66. Klionsky, D. J., K. Abdelmohsen, A. Abe, M. J. Abedin, H. Abeliovich, A. Acevedo-Arozena, H. Adachi, C. M. Adams, P. D. Adams, K. Adeli, et al. 2016. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12: 1-222.
67. Hrecka, K., C. Hao, M. Gierszewska, S. K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M. P. Washburn, and J. Skowronski. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
68. Basmaciogullari, S., and M. Pizzato. 2014. The activity of Nef on HIV-1 infectivity. Front. Microbiol. 5: 232.
69. Rosa, A., A. Chande, S. Ziglio, V. De Sanctis, R. Bertorelli, S. L. Goh, S. M. McCauley, A. Nowosielska, S. E. Antonarakis, J. Luban, et al. 2015. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526: 212-217.
70. Wilen, C. B., J. C. Tilton, and R. W. Doms. 2012. HIV: cell binding and entry. Cold Spring Harb. Perspect. Med. 2: 2.
71. Chiodi, F., and R. A. Weiss. 2014. Human immunodeficiency virus antibodies and the vaccine problem. J. Intern. Med. 275: 444-455.
72. Crotty, S. 2014. T follicular helper cell differentiation, function, and roles in disease. Immunity 41: 529-542.
73. Callahan, K. M., J. F. Rowell, M. J. Soloski, C. E. Machamer, and R. F. Siliciano. 1993. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes. J. Immunol. 151: 2928-2942.
74. Guerbois, M., A. Moris, C. Combredet, V. Najburg, C. Ruffié, M. Février, N. Cayet, S. Brandler, O. Schwartz, and F. Tangy. 2009. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DV1V2 is strongly immunogenic. Virology 388: 191-203.
75. Brandler, S., A. Lepelley, M. Desdouits, F. Guivel-Benhassine, P. E. Ceccaldi, Y. Lévy, O. Schwartz, and A. Moris. 2010. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect. J. Virol. 84: 5314-5328.
76. + T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways. J. Virol. 89: 2698-2709.
77. + and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm-or lysosome-targeted Nef. Blood 107: 1963-1969.
78. Van Gulck, E. R., P. Ponsaerts, L. Heyndrickx, K. Vereecken, F. Moerman, A. De Roo, R. Colebunders, G. Van den Bosch, D. R. Van Bockstaele, V. F. Van Tendeloo, et al. 2006. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood 107: 1818-1827.
79. Tallóczy, Z., W. Jiang, H. W. Virgin, IV, D. A. Leib, D. Scheuner, R. J. Kaufman, E. L. Eskelinen, and B. Levine. 2002. Regulation of starvation-and virusinduced autophagy by the eIF2a kinase signaling pathway. Proc. Natl. Acad. Sci. USA 99: 190-195.
80. Orvedahl, A., S. MacPherson, R. Sumpter, Jr., Z. Tallóczy, Z. Zou, and B. Levine. 2010. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 7: 115-127.
81. Rowell, J. F., A. L. Ruff, F. G. Guarnieri, K. Staveley-O'Carroll, X. Lin, J. Tang, J. T. August, and R. F. Siliciano. 1995. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J. Immunol. 155: 1818-1828.
82. Richetta, C., and M. Faure. 2013. Autophagy in antiviral innate immunity. Cell. Microbiol. 15: 368-376.
83. Mandell, M. A., A. Jain, J. Arko-Mensah, S. Chauhan, T. Kimura, C. Dinkins, G. Silvestri, J. Munch, F. Kirchhoff, A. Simonsen, et al. 2014. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev. Cell 30: 394-409.
84. Imam, S., S. Talley, R. S. Nelson, A. Dharan, C. O'Connor, T. J. Hope, and E. M. Campbell. 2016. TRIM5a degradation via autophagy is not required for retroviral restriction. J. Virol. 90: 3400-3410.
85. Shoji-Kawata, S., R. Sumpter, M. Leveno, G. R. Campbell, Z. Zou, L. Kinch, A. D. Wilkins, Q. Sun, K. Pallauf, D. MacDuff, et al. 2013. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494: 201-206.
86. Terawaki, S., V. Camosseto, F. Prete, T. Wenger, A. Papadopoulos, C. Rondeau, A. Combes, C. Rodriguez Rodrigues, T. P. Vu Manh, M. Fallet, et al. 2015. RUN and FYVE domain-containing protein 4 enhances autophagy and lysosome tethering in response to Interleukin-4. J. Cell Biol. 210: 1133-1152.
87. + T cellular immunity via autophagosome-mediated MHC II molecule-targeting antigen presentation in mice. PLoS One 9: e93143.
88. + T cells after intercellular antigen transfer. J. Immunol. 196: 64-71.